A drug made from a highly purified fat from fish reduced cardiovascular events in people with heart disease or diabetes.
Image: © ksbank/Getty Images
Some people at high risk for a heart attack or stroke now have a new option to help them dodge those dangerous events: a prescription drug that contains large doses of EPA, an omega-3 fatty acid found in fish oil.
In a recent study, the drug, icosapent ethyl (Vascepa), led to dramatic drops in heart attacks, strokes, and deaths from cardiovascular disease in people with high triglycerides (see "What is the REDUCE-IT trial?"). Triglycerides, a type of fat in the blood, have been getting more attention of late for their role in heart disease.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.Sign Me Up
Already a member? Login ».
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.